Macrophagic myofasciitis and vaccination: Consequence or coincidence?
Tóm tắt
Macrophagic myofasciitis (MMF) characterized by specific muscle lesions assessing long-term persistence of aluminum hydroxide within macrophages at the site of previous immunization has been reported with increasing frequency in the past 10 years. We describe clinical and laboratory findings in patients with MMF. We did a retrospective analysis of 16 cases observed in our Neuropathology Laboratory, between January 2000 and July 2013. The mean age of the 16 patients was 48.8 ± 18.0 years; 80.0 % were female. Chronic fatigue syndrome was found in 8 of 16 patients. Half of the patients had elevated creatinine kinase levels, and 25.0 % had a myopathic electromyogram. Thirteen patients received intramuscular administration of aluminum-containing vaccine prior to the onset of symptoms. MMF may mirror a distinctive pattern of an inflammatory myopathy. The vaccines containing this adjuvant may trigger MMF in some patients.
Tài liệu tham khảo
Gherardi RK, Chérin P (1998) Macrophagic fasciitis: a new entity. Groupe d’études et recherche surles maladies musculaires acquises et disimmunitaires (GERMMAD) de l’association française contre les myopathies (AFM). Rev Med Interne 19:617–618
Gherardi RK (2003) Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome. Rev Neurol (Paris) 159:162–164
Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y (2013) Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun 2013(47):1–16. doi:10.1016/j.jaut.2013.10.004
Gherardi RK, Authier FJ (2012) Macrophagic myofasciitis: characterization and pathophysiology. Lupus 21:184–189. doi:10.1177/0961203311429557
Polido Pereira J, Barroso C, Evangelista T, Fonseca JE, Pereira da Silva JA (2011) Macrophagic myofasciitis: a case report of autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Acta Reumatol Port 36:75–76
Barros SM, Carvalho JF (2011) Shoenfeld’s syndrome after pandemic influenza A/H1N1 vaccination. Acta Reumatol Port 36:65–68
Shivane A, Hilton DA, Moate RM, Bond PR, Endean A (2012) Macrophagic myofasciitis: a report of second case from UK. Neuropathol Appl Neurobiol 38:734–736. doi:10.1111/j.1365-2990.2012.01293.x
Exley C, Swarbrick L, Gherardi RK, Authier FJ (2008) A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses 2009(72):135–139. doi:10.1016/j.mehy.2008.09.040
Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y (2013) Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun 47:1–16. doi:10.1016/j.jaut.2013.10.004
Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A et al (2001) Central nervous system disease in patients with macrophagic myofasciitis. Brain 124(974e):83
Migita K, Ueda-Nakata R, Masuda T, Miyashita T, Koga T, Izumi Y, Ichinose K, Ezaki H, Ito M, Motomura M, Eguchi K (2010) Macrophagic myofasciitis associated with rheumatoid arthritis. Rheumatol Int 30(7):987–989. doi:10.1007/s00296-009-1015-3
Lazaro E, Doutre MS, Coquet M, Bouillot S, Beylot-Barry M, Beylot C (2005) Coexistence of dermatomyositis and macrophagic myofasciitis. Presse Med 26(34):438–440
Peter G, des Vignes-Kendrick TC, Eickhoff TC, Fine A, Galvin V, Levine MM, Maldonado YA, Marcuse EK, Monath TP, Osborn JE, Plotkin S, Poland GA, Quinlisk MP, Smith DR, Sokol M, Soland DB, Whitley-Williams PN, Williamson DE, Breiman RF (1999) Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee. Pediatrics 104(4 Pt 1):942–950
Park JH, Na KS, Park YW, Paik SS, Yoo DH (2005) Macrophagic myofasciitis unrelated to vaccination. Scand J Rheumatol 34:65–67
Guis S, Mattei JP, Nicoli F, Pellissier JF, Kaplanski G, Figarella-Branger D, Manez GC, Antipoff GM, Roudier J (2002) Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants? Arthritis Rheum 15(47):543–545
Guis S, Pellissier JF, Nicoli F, Reviron D, Mattei JP, Gherardi RK, Pelletier J, Kaplanski G, Figarella-Branger D, Roudier J (2002) HLA-DRB1*01 and macrophagic myofasciitis. Arthritis Rheum 46:2535–2537